With respect to neurooncology, Tateishi and colleagues (18) examined the interest of using [62Cu]-ATSM for glioma grading and correlated [62Cu]-ATSM uptake with HIF-1α expression in glioma patients. Here, HIF1A is linked to central nervous system cancer.